Drug industry

Article Abstract:

Statistics of some of the companies in the Drug industry and their securities rankings as of October 22, 2004 are furnished. The adverse conditions prevailing in USA are expected to force the government to formulate policies conducive to this sector as the industry forms a very critical part of the countryEs economy. Consequently, the industry and its stocks are expected to gain.

Author: Rho, George, Ferro, Mario, Schlein, Milton, Clark, Charles, Butler, Jeremy J., Markey, Keith A., Rosner, Adam, Ferrara, J. Susan, Harris, Frederick L., Lewittes, William C.

Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004

Industry Overview

User Contributions:

Comment about this article or add new information about this topic:

Drug industry

Article Abstract:

Statistics of some of the companies in the Drug industry and their securities rankings as of October 21, 2005 are furnished. Investors have overreacted to some of the reports of Cox-2 inhibitors. Investments in the companies of this sector in fact have good short-term and long-term prospects.

Author: Rho, George, Ferro, Mario, Schlein, Milton, Clark, Charles, Butler, Jeremy J., Markey, Keith A., Rosner, Adam

Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2005

User Contributions:

Comment about this article or add new information about this topic:

Subjects list: United States, Pharmaceutical industry, Securities, Company securities, Industry forecasts

Similar abstracts:

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.

Abstracts

Business, general

Drug industry

Drug industry